A research team has developed an AI-based personalized cancer vaccine design technology that enables long-term immunity that ...
The team studied a total of 3,79,944 participants without cardiovascular disease at baseline, including 65,047 individuals ...
ELF3 axis enables luminal progenitor transformation in BRCA1-deficient breast cancer by reducing genomic instability and promoting progenitor identity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback